CA2339190C - Compressed compositions comprising clarified xanthan gum - Google Patents

Compressed compositions comprising clarified xanthan gum Download PDF

Info

Publication number
CA2339190C
CA2339190C CA002339190A CA2339190A CA2339190C CA 2339190 C CA2339190 C CA 2339190C CA 002339190 A CA002339190 A CA 002339190A CA 2339190 A CA2339190 A CA 2339190A CA 2339190 C CA2339190 C CA 2339190C
Authority
CA
Canada
Prior art keywords
xanthan gum
sustained release
active ingredient
ibuprofen
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002339190A
Other languages
English (en)
French (fr)
Other versions
CA2339190A1 (en
Inventor
Maureen Dixey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Publication of CA2339190A1 publication Critical patent/CA2339190A1/en
Application granted granted Critical
Publication of CA2339190C publication Critical patent/CA2339190C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002339190A 1998-08-01 1999-07-28 Compressed compositions comprising clarified xanthan gum Expired - Fee Related CA2339190C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents
GB9816723.2 1998-08-01
PCT/EP1999/005499 WO2000007569A1 (en) 1998-08-01 1999-07-28 Compressed compositions comprising clarified xanthan gum

Publications (2)

Publication Number Publication Date
CA2339190A1 CA2339190A1 (en) 2000-02-17
CA2339190C true CA2339190C (en) 2008-11-18

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002339190A Expired - Fee Related CA2339190C (en) 1998-08-01 1999-07-28 Compressed compositions comprising clarified xanthan gum

Country Status (16)

Country Link
EP (1) EP1100471B1 (https=)
JP (1) JP2002522376A (https=)
CN (1) CN1160060C (https=)
AR (1) AR019981A1 (https=)
AT (1) ATE249815T1 (https=)
AU (1) AU744483B2 (https=)
CA (1) CA2339190C (https=)
DE (1) DE69911427T2 (https=)
DK (1) DK1100471T3 (https=)
ES (1) ES2207274T3 (https=)
GB (1) GB9816723D0 (https=)
MX (1) MXPA01000992A (https=)
NZ (1) NZ509593A (https=)
PT (1) PT1100471E (https=)
WO (1) WO2000007569A1 (https=)
ZA (1) ZA200100828B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1610551A (zh) 2001-07-06 2005-04-27 恩德制药公司 用作止痛剂的6－羟基羟吗啡酮的肠胃外给药
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
CA2017249C (en) * 1989-05-24 2000-07-25 Theresa M. Ortega Rheology controlled fabric printing composition and method

Also Published As

Publication number Publication date
DK1100471T3 (da) 2004-01-12
CN1160060C (zh) 2004-08-04
CN1354653A (zh) 2002-06-19
ES2207274T3 (es) 2004-05-16
ATE249815T1 (de) 2003-10-15
DE69911427T2 (de) 2004-07-01
DE69911427D1 (de) 2003-10-23
EP1100471A1 (en) 2001-05-23
EP1100471B1 (en) 2003-09-17
AR019981A1 (es) 2002-03-27
ZA200100828B (en) 2001-10-22
MXPA01000992A (es) 2002-06-04
AU5508799A (en) 2000-02-28
JP2002522376A (ja) 2002-07-23
NZ509593A (en) 2002-12-20
CA2339190A1 (en) 2000-02-17
AU744483B2 (en) 2002-02-28
PT1100471E (pt) 2003-12-31
GB9816723D0 (en) 1998-09-30
WO2000007569A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
EP0234670B1 (en) Sustained-release pharmaceutical formulation containing xanthan gum
CN101330907B (zh) 含普瑞巴林、基质形成剂和溶胀剂并适于每日口服一次的固体药物组合物
FI83037C (fi) Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning.
CN101466359B (zh) 快速释放的对乙酰氨基酚片
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
CN1276719A (zh) 快速崩解的甲基纤维素片剂
CN113908153B (zh) 一种布瓦西坦药物组合物、其制备方法及应用
WO2007010559A2 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
CA2339190C (en) Compressed compositions comprising clarified xanthan gum
PT1146864E (pt) Formulação farmacêutica de libertação prolongada independente de ph
WO2003011256A1 (en) Oral controlled release pharmaceutical composition of a prokinetic agent
WO2006123213A1 (en) Modified release formulations of gliclazide
EP2793853B1 (en) Pharmaceutical formulations of flurbiprofen and glucosamin
CN1172429A (zh) 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
HUE029193T2 (en) Delayed release drug formulations of thiocolchicoside
HK1126394B (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20110728